Delivery Order SPE2DB20D1050-SPE2DB25FH93M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Diclofenac Potassium 50 mg tablets (100-count packages) with a ceiling value of $6,089.81. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is structured as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,946.16 for Diclofenac Potassium 50 mg powder packets (9-count) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 4,565,784,264 units of Diclofenac Potassium 50 mg tablets in 100-count bottles. The contract has a firm-fixed price of $1,931.08 and a completion date of September 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
- The Defense Logistics Agency awarded a $1,272.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac-Misoprostol 50-0.2 mg tablets (60-count units) on July 31, 2025, with completion scheduled for August 1, 2025. This award was not designated as a set-aside contract and represents a routine pharmaceutical procurement through the federal medical supply chain. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $5,219.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac-Misoprostol 75-0.2 mg tablets (60-count) on May 30, 2025, with a completion date of June 2, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be fulfilled from the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.79 to AmerisourceBergen Drug Corp for Diclofenac-Misoprostol 50-0.2 mg tablets (60-count) on August 6, 2025, with completion scheduled for August 7, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,391.14 for Diclofenac-Misoprostol 75-0.2 mg tablets (60 count) on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.56 to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel in 100-gram quantities. This contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award authority. The delivery order is set to complete by September 19, 2025, one day after the award date of September 18, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,462.54, is for the delivery of 100 mg diclofenac sodium extended-release tablets. The contract is a firm-fixed-price delivery order with an ultimate completion date of October 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The Defense Logistics Agency awarded a $1,613.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel in 100-gram units, with an ultimate completion date of September 22, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH93MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Diclofenac Potassium 50 mg tablets (100-count units) with a ceiling value of $4,175.22. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The Diclofenac order exemplifies the routine pharmaceutical procurement executed through this prime vendor arrangement, which provides the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with reliable access to both brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/23/25 |